안구건조증 환자에서 국소 테스토스테론 젤의 치료효과 = Therapeutic Effect of Topical Testosterone Gel in Patients with Dry Eye Syndrome

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate the therapeutic effect of topical testosterone gel application to periocular area in dry eye. Methods: Thirty-four eyes of 17 patients with refractory dry eye were included. Five patients had Sjogren`s syndrome and 12 were non-Sjogren`s syndrome patients. Testosterone gel was applied on the periocular area three times a day. Symptom score corneal sensitivity test (CST), tear film break-up time (BUT), basal tear secretion test (BST), fluorescein staining, tear clearance test (TCR), and conjunctival impression cytology were checked and evaluated before, one month after and two months after treatment. Results: The mean symptom score before topical testosterone gel application was 3.44±0.70; it was 2.88±0.84 at 1 month after application and 2.03±1.09 at 2 months after application. The improvement of tear film parameters including BUT, tear clearance rate, fluorescein staining score, conjunctival metaplasia and goblet cell density was statistically significant (P<0.05) at one and two months after treatment but neither BST nor CST was improved with statistically significance. There was no difference in the therapeutic effect of topical testosterone gel between Sjogren`s syndrome and non-Sjogren`s dry eye patients. Conclusions: The function of tear film and the integrity of ocular surface improved after topical application of testosterone gel in dry eye patients. Topical testosterone gel application may be an effective adjuvant therapy for the treatment of dry eye.

참고문헌 (Reference)

• 1 "Treatment of menopausal keratoconjunctivitis sicca with topical oestradiol" 105 : 100-102, 1998
• 2 "The tear film complex pathogenesis and emerging therapies for dry eyes" 24 : 1-7, 2005
• 3 "The pathology of dry eye" 45 : 211-220, 2001
• 4 "The effect of punctal occlusion in dry eye syndrome" 31 : 851-6, 1990
• 5 "The diagnosis and management of dry eye:A twenty-five-years review" 19 : 644-649, 2000
• 6 "The adrenal cortex" W.B Saunders 517-664, 1998
• 7 "Tear film and ocular surface changes after umbilical cord serum therapy in dry eye syndrome" 46 : 237-242, 2005
• 8 "Tear dynamics and dry eye" 17 : 565-596, 1998
• 9 "Secretion of proinflammatory cytokines by human conjunctival epithelial cells" 5 : 117-128, 1997
• 10 "Report of the National Eye Institute/Industry Workshop on clinical trials in dry eyes" 21 : 221-232, 1995
• 11 "Prevalence of dry eye syndrome among US women" 136 : 318-326, 2003
• 12 "Prevalence and associations of dry eye syndrome in an older population;the Blue-Mountains Eye Study" 37 : 238-245, 2003
• 13 "Overview of Sjogren's syndrome" 66 : 672-4, 1987
• 14 "Influence of androgens and pituitary hormones on the structural profile and secretory activity of the lacrimal gland" 74 : 421-435, 1996
• 15 "Impression cytology" 7 : 71-81, 1988
• 16 "Impact of androgen therapy in Sjogren's syndrome:hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp-lpr/lpr mice" 33 : 2537-45, 1992
• 17 "Identification of androgen receptor protein and 5 alpha-reductase mRNA in human ocular tissues" 84 : 76-84, 2000
• 18 "Hormone replacement therapy and the prevalence of dry eye syndrome" 286 : 2114-2119, 2001
• 19 "Homonal influence on the secretory immune system of the eye:androgen modulation of IgA levels in tears of rats" 134 : 2978-82, 1985
• 20 "Endocrinologic control of the development and activity of the human sebaceous gland" 62 : 191-201, 1974
• 21 "Endocrinologic control of the development and activity of the human sebaceous gland" 62 : 191-201, 1974
• 22 "Effect of androgen deficiency on the human meibomian gland and ocular surface" 85 : 4874-4882, 2000
• 23 "Dry eye diagnosis and management in 2004" 15 : 299-304, 2004
• 24 "Dehydroepiandrosterone therapy for the treatment of dry eye disorders"
• 25 "Control and function of sebaceous glands" 69 : 383-416, 1989
• 26 "Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjogren's syndrome" 35 : 2632-42, 1994
• 27 "Autologous serum eye drops for ocular surface disorders" 88 : 1467-1474, 2004
• 28 "Androgen support of lacrimal gland function" 6 : 39-45, 1997
• 29 "Androgen stimulation of lacrimal gland function in mouse models of Sjogren's syndrome" 60 : 237-245, 1997
• 30 "Androgen influence on the meibomian gland" 41 : 3732-3742, 2000
• 31 "Androgen influence on gene expression in the meibomian gland" 506 : 477-481, 2002